HHS awards $15.2M for Anti-Infective Agent Safety Evaluation to SRI International
Contract Overview
Contract Amount: $15,222,766 ($15.2M)
Contractor: SRI International
Awarding Agency: Department of Health and Human Services
Start Date: 2007-09-30
End Date: 2014-09-29
Contract Duration: 2,556 days
Daily Burn Rate: $6.0K/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 4
Pricing Type: COST PLUS FIXED FEE
Sector: R&D
Official Description: TAS::75 0885::TAS SAFETY EVALUATION OF ANTI-INFECTIVE AGENTS
Place of Performance
Location: MENLO PARK, SAN MATEO County, CALIFORNIA, 94025
Plain-Language Summary
Department of Health and Human Services obligated $15.2 million to SRI INTERNATIONAL for work described as: TAS::75 0885::TAS SAFETY EVALUATION OF ANTI-INFECTIVE AGENTS Key points: 1. Contract awarded for critical research in anti-infective agent safety. 2. SRI International, a large business, secured the award. 3. The contract spans nearly 7 years, indicating a long-term research need. 4. NIH is the awarding agency, focusing on life sciences research.
Value Assessment
Rating: good
The contract value of $15.2M over 7 years suggests a reasonable investment for specialized R&D. Benchmarking against similar NIH contracts for complex research projects would provide further context on pricing efficiency.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, indicating a robust price discovery process. This method generally leads to more competitive pricing as multiple qualified vendors can bid.
Taxpayer Impact: Taxpayer funds are being used for essential research to ensure the safety of anti-infective agents, potentially leading to improved public health outcomes.
Public Impact
Enhances public health by ensuring the safety of critical anti-infective medications. Supports scientific advancement in the field of infectious disease research. Promotes innovation through competitive contracting in the R&D sector.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Contract duration is long (7 years).
- No small business participation noted.
Positive Signals
- Awarded under full and open competition.
- Supports critical public health research.
Sector Analysis
This contract falls within the Research and Development sector, specifically focusing on life sciences. Spending benchmarks for NIH R&D contracts of this nature are typically high due to the specialized expertise and resources required.
Small Business Impact
The contract was awarded to a large business (SRI International) and there is no indication of small business subcontracting. This represents a missed opportunity to engage small businesses in critical research efforts.
Oversight & Accountability
The contract was awarded by the National Institutes of Health, a reputable agency with established oversight mechanisms for research grants and contracts. The long duration suggests ongoing monitoring is likely in place.
Related Government Programs
- Research and Development in the Physical, Engineering, and Life Sciences
- Department of Health and Human Services Contracting
- National Institutes of Health Programs
Risk Flags
- Long contract duration.
- No small business participation.
- Potential for scope creep in long-term R&D.
- Cost-plus contract type can lead to higher costs.
Tags
research-and-development-in-the-physical, department-of-health-and-human-services, ca, definitive-contract, 10m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Health and Human Services awarded $15.2 million to SRI INTERNATIONAL. TAS::75 0885::TAS SAFETY EVALUATION OF ANTI-INFECTIVE AGENTS
Who is the contractor on this award?
The obligated recipient is SRI INTERNATIONAL.
Which agency awarded this contract?
Awarding agency: Department of Health and Human Services (National Institutes of Health).
What is the total obligated amount?
The obligated amount is $15.2 million.
What is the period of performance?
Start: 2007-09-30. End: 2014-09-29.
What is the specific scientific impact expected from this evaluation of anti-infective agents?
The evaluation is expected to identify potential safety concerns or confirm the safety profile of various anti-infective agents. This directly impacts drug development pipelines, regulatory approvals, and ultimately, patient safety by ensuring that treatments are both effective and safe for public use.
Are there any identified risks associated with the long-term nature of this contract?
The primary risk of a long-term contract is potential cost overruns if initial estimates are inaccurate or if research scope significantly expands. Additionally, scientific priorities can shift over 7 years, potentially making the research less relevant or requiring substantial adaptation, impacting overall value.
How does this contract contribute to the overall effectiveness of the nation's anti-infective drug supply?
By rigorously evaluating the safety of anti-infective agents, this contract directly contributes to the effectiveness of the nation's drug supply. It helps prevent the approval or continued use of unsafe medications, ensuring that the available treatments are reliable and pose minimal risk to patients, thereby maintaining public trust and health.
Industry Classification
NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in the Physical, Engineering, and Life Sciences
Product/Service Code: RESEARCH AND DEVELOPMENT › N – Health R&D Services
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: BASIC RESEARCH
Solicitation ID: NIH NIAID DAIDS 07 24
Offers Received: 4
Pricing Type: COST PLUS FIXED FEE (U)
Evaluated Preference: NONE
Contractor Details
Address: 333 RAVENSWOOD AVE, MENLO PARK, CA, 94025
Business Categories: Category Business, Nonprofit Organization, Not Designated a Small Business
Financial Breakdown
Contract Ceiling: $15,429,708
Exercised Options: $15,222,766
Current Obligation: $15,222,766
Contract Characteristics
Commercial Item: COMMERCIAL ITEM PROCEDURES NOT USED
Timeline
Start Date: 2007-09-30
Current End Date: 2014-09-29
Potential End Date: 2014-09-29 00:00:00
Last Modified: 2019-09-12
More Contracts from SRI International
- - NEW Award to Support the Army National Guard Exportable Combat Training Capability (xctc) — $155.5M (Department of the Interior)
- U437D00 Desert OWL Oconus Operational Assessment — $140.8M (Department of Defense)
- 8506396549! Contract, Procurement, and ACQ SPT Svcs — $69.9M (Department of Defense)
- Exportable Combat Training Capability (xctc) Training Services — $60.6M (Department of the Interior)
- Ot8507954814spe7l121f172dp00002 — $60.3M (Department of Defense)
Other Department of Health and Human Services Contracts
- Contact Center Operations (CCO) — $5.5B (Maximus Federal Services, Inc.)
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Leidos Biomedical Research Inc)
- THE Purpose of This Contract IS to Provide the Full Complement of Services Necessary to Care for UC in ORR Custody Including Facilities Set-Up, Maintenance, and Support Internal and Perimeter (IF Applicable) Security, Direct Care and Supervision Inc — $3.5B (Rapid Deployment Inc)
- Contact Center Operations — $2.6B (Maximus Federal Services, Inc.)
- Federal Contract — $2.4B (Leidos Biomedical Research Inc)
View all Department of Health and Human Services contracts →